Carvacrol as a Therapeutic Candidate in Breast Cancer: Insights into Subtype-Specific Cellular Modulation
Carvacrol exerts multitargeted anticancer effects in BC by promoting apoptosis, reducing ROS, and suppressing CD44<sup>+</sup>, with distinct subtype-specific responses. These findings highlight carvacrol as a promising natural therapeutic compound for BC treatment; however, further in vivo studies and clinical investigations are required to validate its translational potential.
Authors
- Berrin Papila Kundaktepe (ORCID: https://orcid.org/0000-0003-4394-3976)
- Tarık MECİT (ORCID: https://orcid.org/0000-0002-3816-134X)
- Selman Emiroğlu (ORCID: https://orcid.org/0000-0001-9333-6926)
- Barış Yıldız (ORCID: https://orcid.org/0000-0002-8432-4656)
- Serkan Akbaş (ORCID: https://orcid.org/0000-0002-5150-2727)
- Halil Ibrahim Arslan (ORCID: https://orcid.org/0009-0001-4172-4748)
- Asmaa Abuaısha (ORCID: https://orcid.org/0000-0003-2869-6620)
- Esra Sert (ORCID: https://orcid.org/0000-0002-7383-8619)
- Cüneyd Yavaş (ORCID: https://orcid.org/0000-0002-1597-5922)
- Özgür Yılmaz (ORCID: https://orcid.org/0009-0000-4976-4771)
- Emir Nekay
- Aybuke Hilal Gumus
Institutions
- Kafkas University (TR)
- Biruni University (TR)
- Istanbul University-Cerrahpaşa (TR)
- İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi (TR)
- Istanbul University (TR)
Publication Details
- Journal
- Biology
- Published
- 2025-10-19
- DOI
- https://doi.org/10.3390/biology14101443
- Citations
- 3
- Primary Topic
- Coenzyme Q10 studies and effects
- Type
- article
- Field-Weighted Citation Impact
- 2.42